Epclusa Approved for Children With Any Hep C Genotype
FRIDAY, March 20, 2020 -- Epclusa (sofosbuvir and velpatasvir) received approval for a supplemental application to treat hepatitis C virus (HCV) in children without cirrhosis or with mild cirrhosis, the U.S. Food and Drug Administration announced...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Children | Cirrhosis | Food and Drug Administration (FDA) | General Medicine | Hepatitis | Hepatitis C